DSIJ Mindshare

Promoter of defence multibagger stock acquires additional 2,39,800 shares through open offer of this gems and jewelry company

Critical components catering to the defence industry. In addition to this, the company also offers strategic products and related research advancements in the E-Vehicles division and the BVM R&D Foundation.

Karan Dsij 0 12924 Article rating: 4.4

Hitting its upper circuit limit of 5 per cent on the BSE. The stock has seen a remarkable surge of 132.49 per cent in the past three months, with multibagger returns of 349.73 per cent over the last year.

Multibagger stock below Rs 20: Aditya Birla Group's stock big fundraising plans; will it be an alpha generator? Promoters to participate!

The stock has demonstrated remarkable resilience, yielding multibagger returns of 133.09 per cent over the past year.

Karan Dsij 0 15339 Article rating: 3.9

The Company aims to mobilize approximately Rs. 45,000 crore, harnessing the combined potential of equity and debt instruments. At present, the Company's bank debt stands conservatively at less than Rs. 4,500 crore, underscoring its prudent fiscal stewardship.

Promoter buying penny stock below Rs 5: Multibagger penny stock with a history of 38 years and 15,000 dealers; watch out!

A robust distribution network comprising 15,000 dealers and distributors.

Karan Dsij 0 3951 Article rating: 3.4

DIVIJ SHANTILAL SHAH had acquired 54,000 equity shares of  at an average price of Rs. 3.2, underscoring confidence in the company's trajectory.

Mukul Agrawal and Tata AIA-backed defence small-cap multibagger stock received a big order from the Ministry of Defence, company aims for Rs 900 crore in revenue!

The company aims to strengthen its order book position by the end of FY'25 compared to FY'24.

Karan Dsij 0 15172 Article rating: 4.3

With a target revenue of 900 crore for FY25 and a trailing twelve-month (TTM) revenue of Rs 369 crore, the company envisions robust growth. It expects macro factors to facilitate a minimum CAGR growth rate of 50 per cent from FY'26 to '28, sustaining the trajectory initiated.

Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds!

The company saw strong volume growth across key markets, particularly the US, indicating rising demand for their products.

Aniket Gogate 0 7799 Article rating: 4.0

Institutional investor interest in the stock has risen significantly, with Foreign Institutional Investor (FII) holdings increasing to 15.55 per cent in the quarter ending December 2023 from 4.23 per cent in December 2022.

RSS
1345678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR